1-12 of 12
Shlomzion Aumann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin-Based Regimens for Older Patients with Newly Diagnosed Classical Hodgkin Lymphoma - International, Multi-Center Real-World Experience

Efrat Luttwak, Swetha Kambhampati, Esther Drill, Nivetha Ganesan, Liron Hofstetter, Ronit Gurion, Shlomzion Aumann, Arnon Haran, Mika Geva, Marc Panossian, Robert Stuver, Paul A. Hamlin, Ariela Noy, Alex F. Herrera, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1668.
https://doi.org/10.1182/blood-2024-212085
Published: 2024
Journal Articles

For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious

Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Boaz Nachmias, Hazim Khatib, Arnon Haran, Shlomzion Aumann
Journal: Blood
Blood (2024) 144 (Supplement 1): 4269.
https://doi.org/10.1182/blood-2024-204627
Published: 2024
Journal Articles

UBE2E3 Supports Survival of Leukemia Stem Cells By Regulation of Polycomb Repression Complex (PRC) 1.1

Vika Miller, Ayat Hija, Mohamed Abdal-Rhaman, Noa Gross Even-Zohar, Michal Saltsman, Aaron Botham, Arnon Haran, Shlomzion Aumann, Vladimir Vainstein, Moshe E Gatt, Brian Raught, Aaron D Schimmer, Boaz Nachmias
Journal: Blood
Blood (2024) 144 (Supplement 1): 5714.
https://doi.org/10.1182/blood-2024-193438
Published: 2024
Journal Articles

DNMT3A, TET2, and ASXL1 (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms

Arnon Haran, Avital Wasserstrom, Shlomzion Aumann, Vladimir Vainstein, Romi Kazoom, Batia Roth Jelinek, Ariela Arad, Noa Buchman, Ela Shai, Yossi Kalish, Moshe E Gatt, Eran Zimran
Journal: Blood
Blood (2024) 144 (Supplement 1): 3189.
https://doi.org/10.1182/blood-2024-209783
Published: 2024
Journal Articles

Epcoritamab for Relapsed/Refractory B Cell Lymphoma - the Israeli Real-World Experience of a Compassionate Use Program

Shlomzion Aumann, Abraham Avigdor, Ronit Marcus, Netanel A. Horowitz, Ronit Gurion, Tamar Tadmor, Roy Vitkon, May Meira Basood, Uri Abadi, Meirav Kedmi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5124.
https://doi.org/10.1182/blood-2024-198926
Published: 2024
Journal Articles

Efficacy and Safety of Glofitamab in Patients with R/R DLBCL in Real Life Setting - a Retrospective Study

Ronit Gurion, Dmitri Guz, Meirav Kedmi, Chava Perry, Irit Avivi Mazza, Netanel A. Horowitz, Uri Abadi, Anat Gafter-Gvili, Pia Raanani, Neta Goldschmidt, Boaz Nachmias, Shlomzion Aumann
Journal: Blood
Blood (2023) 142 (Supplement 1): 5170.
https://doi.org/10.1182/blood-2023-186033
Published: 2023
Journal Articles

Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma

Arnon Haran, Noa Gros Even-Zohar, Eyal Lebel, Shlomzion Aumann, Adir Shaulov, Moshe E Gatt, Boaz Nachmias
Journal: Blood
Blood (2023) 142 (Supplement 1): 6277.
https://doi.org/10.1182/blood-2023-187241
Published: 2023
Journal Articles

The Utility of a Coagulation Laboratory Profile in Addition to Clinical Risk Factors for Thrombosis Risk Evaluation in Patients with Myeloproliferative Neoplasms: A Pilot Study

Inbal Shapira, Ela Shai, Yossef Kalish, Uria Tsubary, Shlomzion Aumann, Ariela Arad, Batia Roth Jelinek, Noa Buchman, Moshe E Gatt, Eran Zimran
Journal: Blood
Blood (2023) 142 (Supplement 1): 6401.
https://doi.org/10.1182/blood-2023-187136
Published: 2023
Journal Articles

Obinutuzumab Versus Rituximab Based First-Line Chemoimmunotherapy for Follicular Lymphoma - a Real-World Multicenter Retrospective Cohort Study

Tamar Berger, Tzippy Shochat, Shlomzion Aumann, Boaz Nachmias, Neta Goldschmidt, Nurit Horesh, Reut Harel, Ariel Aviv, Ella Shmerts, Uri Abadi, Pia Raanani, Anat Gafter-Gvili, Ronit Gurion
Journal: Blood
Blood (2022) 140 (Supplement 1): 11947–11948.
https://doi.org/10.1182/blood-2022-159881
Published: 2022
Journal Articles

COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic

Shlomzion Aumann, Uria Tsubary, Sarah Israel, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, Vladimir Vainstein, Diana Libster, Revital Saban, Adir Shaulov, Batia Avni, Boaz Nachmias, Sigal Grisariu, Ora Paltiel, Moshe Gatt, Eran Zimran
Journal: Blood
Blood (2021) 138 (Supplement 1): 4088.
https://doi.org/10.1182/blood-2021-148512
Published: 2021
Journal Articles

Genomic Analysis of Serial Samples from CLL Patients Identifies Clonal Events Associated with Disease Progression

Jeffrey R Gardner, BS, MBA, Michelle Nahas, PhD, Jie He, PhD, Shlomzion Aumann, Mithat Gonen, Minal Patel, Kristina M. Knapp, BS, Maria Lia Palomba, MD, Roman Yelensky, PhD, Amy L Donahue, MS, Geoff Otto, PhD, Maria Arcila, MD, Nicole Lamanna, Mark G. Frattini, MD PhD, Ahmet Dogan, MD PhD, Jae H Park, MD, Doron Lipson, PhD, Martin S. Tallman, MD, Ross L. Levine, MD, Philip J. Stephens, PhD, Marcel R. M. van den Brink, MD PhD, Mark L Heaney, MD PhD, Vincent A. Miller, MD, Andrew D. Zelenetz, MD PhD, Omar Abdel-Wahab, MD
Journal: Blood
Blood (2014) 124 (21): 1954.
https://doi.org/10.1182/blood.V124.21.1954.1954
Published: 2014
Journal Articles

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Brief Report
Jean-François Emile, Eli L. Diamond, Zofia Hélias-Rodzewicz, Fleur Cohen-Aubart, Frédéric Charlotte, David M. Hyman, Eunhee Kim, Raajit Rampal, Minal Patel, Chezi Ganzel, Shlomzion Aumann, Gladwys Faucher, Catherine Le Gall, Karen Leroy, Magali Colombat, Jean-Emmanuel Kahn, Salim Trad, Philippe Nizard, Jean Donadieu, Valérie Taly, Zahir Amoura, Omar Abdel-Wahab, Julien Haroche
Journal: Blood
Blood (2014) 124 (19): 3016–3019.
https://doi.org/10.1182/blood-2014-04-570937
Published: 2014
Includes: Supplemental data